A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects

Clinical trial NCT01221818 · COMPLETED

Trial details

NCT number: NCT01221818
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammatory Bowel Disease

Start date: 2010-09-01
Primary completion: 2011-10-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.